Contract notice
Section I: Contracting
authority
I.1) Name and addresses
National Institute For Health And Care Excellence
Level 1 City Tower
Manchester
M14BT
UK
Contact person: Irene Walker
Telephone: +44 1618703198
E-mail: irene.walker@nice.org.uk
NUTS: UKD
Internet address(es)
Main address: https://www.nice.org.uk/
Address of the buyer profile: https://www.nice.org.uk/
I.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge at:
https://www.gov.uk/contracts-finder
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be sent to the following address:
National Institute for Health and Care Excellence
Level 1 City Tower
Manchester
M14BT
UK
Contact person: Irene Walker
E-mail: contract.bids@nice.org.uk
NUTS: UKD3
Internet address(es)
Main address: https://www.nice.org.uk/
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
External Assessment Centres Framework
Reference number: NICEEACF22
II.1.2) Main CPV code
73000000
II.1.3) Type of contract
Services
II.1.4) Short description
NICE is seeking to commission external assessment centres (EACs) which will provide a range of health technology assessment (HTA) services to support its technology evaluation programmes and related activities (see above). Suppliers must be able to provide all services within Lots 1 and 2, for Lot 3, 3a or 3b to bid for that Lot. Suppliers need to be able to provide only the services within a work package to bid for any of the work packages within Lot 4.
Suppliers can bid for one or more Lots.
NICE will consider bids from multidisciplinary centres with knowledge and expertise in health technology assessment, enhanced for Lots 1 and 3 by a close association with frontline clinical services in areas related to medical technologies such as imaging or in vitro diagnostics.
Suppliers intending to provide services in Lot 2 will have significant expertise and experience of advanced HTA methods and be able to provide the service in relation to pharmaceuticals, medical, digital and diagnostic technologies.
NICE will consider proposals from consortia or networks of organisations meeting the selection criteria and encourages potential suppliers to explore collaborations that will result in the offer of a comprehensive range of services.
II.1.5) Estimated total value
Value excluding VAT:
5 884 000.00
GBP
II.1.6) Information about lots
This contract is divided into lots:
Yes
Tenders may be submitted for all lots
II.2) Description
Lot No: 1
II.2.1) Title
Clinical and Economic Evidence Assessment
II.2.2) Additional CPV code(s)
73000000
II.2.3) Place of performance
NUTS code:
UKD
II.2.4) Description of the procurement
Including: critical appraisal of submitted evidence to support the development of NICE outputs; evidence synthesis; de novo economic modelling and critiquing and revising existing models; updating information and evidence on technologies to support guidance review; preparation of evidence summaries on new and novel technologies; systematic review and meta-analysis; market intelligence analysis; supporting identification, topic selection and scoping of medtech products, confirmations of regulatory status for medtech products.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 33
This contract is subject to renewal: No
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
Yes
Description of options:
Options to extend for 1 x 15 months period
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
II.2.14) Additional information
NICE has had numerous technical issues issuing the notice onto Find a Tender. The notice was published on Contracts Finder on the 15th November 2021.
Lot No: 2
II.2.1) Title
Decision and methodological support services
II.2.2) Additional CPV code(s)
73000000
II.2.3) Place of performance
NUTS code:
UKD
II.2.4) Description of the procurement
Including: providing technical support to evaluation programmes; advanced methodological development for all types of health technologies, including pharmaceuticals, medical and diagnostic technologies and related products; providing educational support; providing advanced methodological, analytical and other ad hoc support to NICE and its independent advisory bodies on the assessment of medicines and medical technologies; providing quality assurance of economic models and other Supplier outputs; providing training on HTA and related disciplines and developing online training resources on HTA for NICE staff and committee members; evidence searching; systematic review and meta-analysis; de-novo modelling.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 33
This contract is subject to renewal: No
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
Yes
Description of options:
Option to extend for 1 x 15 months periods
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
II.2.14) Additional information
NICE has had numerous technical issues issuing the notice onto Find a Tender. The notice was published on Contracts Finder on the 15th November 2021.
Lot No: 3
II.2.1) Title
Primary data generation and analysis and Real World Evidence Generation for Managed Access
II.2.2) Additional CPV code(s)
73000000
II.2.3) Place of performance
NUTS code:
UKD
II.2.4) Description of the procurement
3a - Primary data generation and analysis
Including: protocol development for promising technologies where the available evidence is insufficient to recommend routine adoption; pragmatic facilitation of collaborative research acting as the academic lead and research sponsor where needed, on clinical, laboratory, and methodological projects investigating the clinical utility of specific healthcare technologies; real-world evidence collection activities including establishing patient registries, analysing register data, and similar schemes; the specification, compilation, validation and analysis of datasets including linkage with other "real-life" data sources. This may include analysis of data protection/ information governance and preparation of paperwork as required. The Supplier may be required to manage a third party to undertake data collection and analysis, developing the contractual paperwork and holding the budget for the work as necessary.
Lot 3b - Real World Evidence Generation for Managed Access
Including: Managed Access evidence generation using existing registers or databases, feasibility studies, data protocol development, pilot studies; data collection and active surveillance; active data surveillance; grant applications; data linkage and complex modelling and/or analyses; register close down; journal publications
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 33
This contract is subject to renewal: No
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
Yes
Description of options:
option to extend for 1 x 15months periods
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
II.2.14) Additional information
NICE has had numerous technical issues issuing the notice onto Find a Tender. The notice was published on Contracts Finder on the 15th November 2021.
Lot No: 4
II.2.1) Title
Multiple services
II.2.2) Additional CPV code(s)
73000000
II.2.3) Place of performance
NUTS code:
UKD
II.2.4) Description of the procurement
Lot 4a - Clinical and Economic Evidence Assessment - additional capacity
Including: critical appraisal of submitted evidence to support the development of NICE outputs; evidence synthesis; de novo economic modelling and critiquing and revising existing models; updating information and evidence on technologies to support guidance review; preparation of evidence summaries on new and novel technologies; systematic review and meta-analysis; market intelligence analysis; supporting identification, topic selection and scoping of medtech products, confirmations of regulatory status for medtech products.
Lot 4b - Decision and methodological support services - additional capacity
Including: providing technical support to evaluation programmes; advanced methodological development for all types of health technologies, including pharmaceuticals, medical and diagnostic technologies and related products; providing educational support; providing advanced methodological, analytical and other ad hoc support to NICE and its independent advisory bodies on the assessment of medicines and medical technologies; providing quality assurance of economic models and other Supplier outputs; providing training on HTA and related disciplines and developing online training resources on HTA for NICE staff and committee members; evidence searching; systematic review and meta-analysis; de-novo modelling.
Lot 4c - Supplementary services - Research & ethics
Including: advice on research governance and ethics support including access to a research ethics committee.
Lot 4d - Supplementary services - Technical assessment
Including: technical assessment to inform on effective use.
The following sections list the general approach NICE takes to the work carried out by the EACs, followed by details of work packages issued under each Lot and specific details of the modules of work generally included in standard work packages.
II.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
II.2.7) Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 33
This contract is subject to renewal: No
II.2.9) Information about the limits on the number of candidates to be invited
II.2.10) Information about variants
Variants will be accepted:
No
II.2.11) Information about options
Options:
Yes
Description of options:
Option to extend for 1 x 15 months periods
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
II.2.14) Additional information
NICE has had numerous technical issues issuing the notice onto Find a Tender. The notice was published on Contracts Finder on the 15th November 2021.
Section III: Legal, economic, financial and technical information
III.1) Conditions for participation
III.1.2) Economic and financial standing
Selection criteria as stated in the procurement documents
III.1.3) Technical and professional ability
Selection criteria as stated in the procurement documents
III.2) Conditions related to the contract
III.2.1) Information about a particular profession
Participation is reserved to a particular profession: Yes
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.3) Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement with several operators.
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
No
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2021/S 000-009332
IV.2.2) Time limit for receipt of tenders or requests to participate
Date:
22/12/2021
IV.2.4) Languages in which tenders or requests to participate may be submitted
EN
IV.2.7) Conditions for opening of tenders
Date:
23/12/2021
Local time: 11:00
Section VI: Complementary information
VI.1) Information about recurrence
This is a recurrent procurement:
No
VI.4) Procedures for review
VI.4.1) Review body
National Institute for Health and Care Excellence (NICE)
Level 1 City Tower
Manchester
M14BT
UK
VI.5) Date of dispatch of this notice
01/12/2021